This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genticel. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Michael Esquerré
Introduction
Michael Esquerré is a notable inventor based in Toulouse, France. He has made significant contributions to the field of immunotherapy through his innovative research and development. His work focuses on the use of CyaA-carried polypeptides to induce immune responses in mammalian hosts.
Latest Patents
Michael Esquerré holds a patent for "CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses." This invention is directed towards immunotherapeutic treatments for specific pathological conditions diagnosed in mammals. It aims to elicit T cell immune responses against a group of epitopes contained in the polypeptides, thereby providing both therapeutic and prophylactic benefits.
Career Highlights
Esquerré is currently associated with Genticel, a company that focuses on innovative solutions in the field of immunotherapy. His work has been instrumental in advancing the understanding and application of immune responses in therapeutic settings. He has a proven track record of innovation, with a total of 1 patent to his name.
Collaborations
Throughout his career, Michael has collaborated with talented individuals such as Marie Momot and Anne Goubier. These collaborations have further enriched his research and contributed to the success of his projects.
Conclusion
Michael Esquerré's contributions to immunotherapy through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire and pave the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile